Effects of glycemic control on target organ responses to epinephrine in type 1 diabetes

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 2 52-2, 2005, Pages

  Guy, Deanna Aftab ^a   Sandoval, Darleen ^a   Richardson, M A ^a   Tate, Donna ^a   Davis, Stephen N ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Catecholamines; Glucose clamp technique; Intensive glucose control; Metabolic target organ

Indexed keywords

ADRENALIN; GLUCOSE; INSULIN;

ADIPOSE TISSUE; ADULT; ARTICLE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; HORMONE ACTION; HORMONE RESISTANCE; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIVER; MALE; METABOLIC REGULATION; MUSCLE; MUSCLE BIOPSY; PANCREAS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADIPOSE TISSUE; ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; EPINEPHRINE; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIVER; MALE; MUSCLE, SKELETAL; NOREPINEPHRINE; STATISTICS, NONPARAMETRIC; SYMPATHOMIMETICS;

EID: 23044486069     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00311.2004     Document Type: Article

References (42)

1. Abumrad NN, Rabin D, Diamond MC, and Lacy WW. Use of a heated superficial hand vein as an alternative site for measurement of amino acid concentration and for the study of glucose and alanine kinetics in man. Metabolism 30: 936-940, 1981.
2. Aftab Guy D, Sandoval D, Richardson M, Tate D, Flakoll PJ, and Davis SN. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans. Am J Physiol Endocrinol Metab 288: E178-E186, 2005.
3. Aguilar-Parada E, Eisentraut AM, and Unger RH. Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci 257: 415-419, 1969.
4. Amiel SA. R. D. Lawrence Lecture 1994. Limits of normalitly: The mechanisms of hypoglycemic unawareness. Diabet Med 11: 918-924, 1994.
5. Amiel SA, Sherwin RS, Simonson D, and Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37: 901-907, 1988.
6. Amiel SA, Simonson DC, Sherwin RS, Lauritano AA, and Tamborlane WV. Exaggerated epinephrine response to to hypoglycemia in normal and insulin dependent diabetic children. J Pediatr 110: 832-837, 1987.
7. Amiel SA, Tamborlane WV, Simonson DC, and Sherwin RS. Defective glucose counterregulation after strict control of insulin-dependent diabetes mellitus. N Engl J Med 316: 1376-1383, 1987.
8. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35: 609-616, 1975.
9. Boden G, Cheung P, Stein T, Kresge K, and Mozzoli M. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am J Physiol Endocrinol Metab 283: E12-E19, 2002.
10. Bruss ML and Black AL. Enzymatic microdetermination of glycogen. Anal Biochem 84: 309-312, 1978.
11. Causon R, Caruthers M, and Rodnight R. Assay of plasma catecholamines by liquid chromatography with electrical detection. Anal Biochem 116: 223-226, 1982.
12. Cherrington AD. The Acute Regulation of Hepatic Glucose Production. In: The Role of the Liver in Maintaining Glucose Homeostasis, edited by Pagliassotti MJ, Davis SN, and Cherrington AD. Austin, TX: R. G. Landes, 1994, p. 19-43.
13. Cherrington AD, Lacy WW, and Chiasson JL. Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest 62: 664-667, 1978.
14. Chu CA, Sindelar D, Neal D, Allen E, Donahue P, and Cherrington A. Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. J Clin Invest 99: 1044-1056, 1997.
15. Cox D, Cryer PE, Gonder-Frederick L, Clarke WL, and Antain B. Perceived symptoms in the recognition of hypoglycemia. Diabetes Care 16: 519-527, 1993.
16. Cryer PE and Gerich JE. Glucose counterregulation, hypoglycemia and intensive insulin therapy in diabetes mellitus. N Engl J Med 313: 232-241, 1985.
17. Davis SN, Shavers C, Allen E, and Mosqueda-Garcia R. Antecedent hypoglycemia causes deficient subsequent counterregulation via increases in cortisol levels. J Clin Invest 98: 680-691, 1996.
18. DeFronzo RA, Tobin K, and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E216-E223, 1979.
19. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634, 1983.
20. Fritsche A, Stefan N, Haring H, Gerich J, and Stumvoll M. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes. Ann Intern Med 134: 729-736, 2001.
21. Fritsche A, Stumvoll M, Haring HU, and Gerich JE. Reversal of hypoglycemia unawareness in a long-term type 1 diabetic patient by improvement of beta-adrenergic sensitivity after prevention of hypoglycemia. J Clin Endocrinol Metab 85: 523-525, 2000.
22. Gerich J, Langlois M, Noacco C, Schneider V, and Forsham PH. Adrenergic modulation of pancreatic glucagon secretion in man. J Clin Invest 53: 1441-1446, 1974.
23. Gerich J, Lorenzi M, Tsalikian E, and Karam J. Studies on the mechanism of epinephrine-induced hyperglycemia in man. Diabetes 25: 65-71, 1976.
24. Gerich JE, Langlois M, Noacco C, Karam J, and Forsham PH. Lack of a glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha-cell defect. Science 182: 171-173, 1973.
25. Golden S, Wals PA, and Katz J. An improved procedure for the assay of glycogen synthase and phosphorylase in rat liver homogenates. Anal Biochem 77: 436-445, 1977.
26. Guinovart J, Salavert A, Massague J, Ciudad C, Salsas E, and Itarte E. Glycogen synthase: a new activity ratio assay expressing a high sensitivity to the phosphoyrlation state. FEBS Lett 106: 284-288, 1979.
27. Hagopian W, Lever E, Cohen D, Emmanouel D, Polonsky K, Pugh W, Moosa A, and Jaspan JB. Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog. Am J Physiol Endocrinol Metab 245: E171-E177, 1983.
28. Hawkins M, Gabriely I, Wozniak R, Reddy K, Rossetti L, and Shamoon H. Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects. Diabetes 51: 2179-2189, 2002.
29. Ho RJ. Radiochemical assay of long chain fatty acid using 63N1 as tracer. Anal Biochem 26: 105-113, 1970.
30. Horwitz W. Official Methods of Analysis of the Association of Official/Analytical Chemists. Washington, DC: AOAC, 1975.
31. 131I]-labeled human growth hormone of high specific activity. Nature 194: 495-496, 1962.
32. Kinsley BT, Widom B, Utzschneider K, and Simonson DC. Stimulus specificity of defects in counterregulatory hormone secretion in insulin-dependent diabetes mellitus: effect of glycemic control. J Clin Endocrinol Metab 79: 1383-1389, 1994.
33. Lafontan M and Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34: 1057-1091, 1993.
34. Laurent D, Falk Petersen K, Russell RR, Cline GW, and Shulman GI. Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans. Am J Physiol Endocrinol Metab 274: E130-E138, 1998.
35. Lloyd B, Burrin J, Smythe P, and Alberti KGMM. Enzymatic fluorometric continuous-flow assays for blood glucose lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem 24: 1724-1729, 1978.
36. Raz I. Epinephrine inhibits insulin-mediated glycogenesis but enhances glycolysis in human skeletal muscle. Am J Physiol Endocrinol Metab 260: E430-E435, 1991.
37. Sacca L, Vigorito C, Cicala M, Corso G, and Sherwin RS. Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans. Am J Physiol Endocrinol Metab 245: E294-E302, 1983.
38. Sherwin RS, Kramer K, Robin J, and Andres R. A model of the kinetics of insulin in man. J Clin Invest 53: 1481-1492, 1974.
39. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabtetes mellitus. N Engl J Med 329: 977-986, 1993.
40. The Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90: 450-459, 1991.
41. Wall JS, Steele R, DeBodo RD, and Altszuler N. Effect of insulin on utilization and production of circulating glucose. Am J Physiol 189: 43-50, 1957.
42. Wide L and Porath J. Radioimmunoassay of proteins with the use of sephadex-coupled antibodies. Biochim Biophys Acta 130: 257-260, 1966.